Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001488369 | SCV001692883 | likely benign | Noonan syndrome 9 | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001762699 | SCV001988883 | benign | not provided | 2021-07-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002432371 | SCV002730188 | likely benign | Cardiovascular phenotype | 2021-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001488369 | SCV002763046 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Prevention |
RCV003965993 | SCV004782470 | likely benign | SOS2-related disorder | 2019-09-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |